Extended Progression-Free Survival of Renal Cell Carcinoma With Axitinib: Case Report

Journal of Urology and Renal Diseases
doi 10.29011/2575-7903.001102
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Gavin Publishers

Related search

Axitinib for the Management of Metastatic Renal Cell Carcinoma

Drugs in R and D
Pharmacology
2011English

Long-Term Survival in a Case of Renal Cell Carcinoma With Brain Metastases: A Case Report

Clinical Medicine Insights: Case Reports
Medicine
2019English

Predictors of Progression-Free Survival and Overall Survival in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Single-Center Experience

World Journal of Oncology
Cancer ResearchOncology
2019English

Axitinib Plus Pembrolizumab Is Effective in Renal Cell Carcinoma

Cancer Discovery
Oncology
2018English

A Case Report of Esophageal Carcinoma With Metachronous Renal Cell Carcinoma.

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
1991English

Renal Cell Carcinoma Presenting With Cutaneous Metastasis: Case Report

Turk Onkoloji Dergisi
Oncology
2013English

Development and Validation of a Prognostic Nomogram for Progression-Free Survival in Patients With Advanced Renal Cell Carcinoma Treated With Pazopanib

Oncology
MedicineCancer ResearchOncology
2015English

Renal Tuberculosis Mimicking Renal Cell Carcinoma: A Case Report

Journal of Medical Case Reports
Medicine
2019English

Papillary Renal Cell Carcinoma With Extensive Osseous MetaplasiaA Case Report

Annals of Pathology and Laboratory Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy